Skip to main content
Download PDF

Gut microbiota changes in horses with Chlamydia

BMC Microbiology volume 23, Article number: 246 (2023) Cite this article

Abstract

Background

Zoonotic diseases pose a significant threat to public health. Chlamydia, as an intracellular pathogen, can colonize the intestinal tract of humans and animals, changing the gut microbiota. However, only a few studies have evaluated alterations in the gut microbiota of horses infected with Chlamydia. Therefore, this study aimed to investigate gut microbiota and serum biochemical indicators in horses with Chlamydial infection (IG) and healthy horses (HG). Fecal and blood samples were collected from 16 horses (IG: 10; HG: 6) before morning feeding for the determination of gut microbiota and serum biochemical parameters.

Results

The results showed that total globulin (GLB), alanine aminotransferase (ALT), and creatine kinase (CK) levels were significantly increased in IG compared with HG. Notably, the gut microbial diversity increased in IG compared with HG. Furthermore, Moraxellaceae and Akkermanisa abundance decreased in IG, while Streptococcus, Treponema, Prevotella, and Paraprevotella abundances (13 genera of bacterial species) increased. Compared with HG, carbohydrate metabolism increased in IG while amino acid metabolism decreased. In addition, the abundance of 18 genera of bacteria was associated with the level of five serum biochemical indicators.

Conclusions

In summary, this study elucidated the influence of Chlamydia infection in horses on the gut microbiota, unraveling consequential alterations in its composition and metabolic profile. Therefore, this study improves the understanding of Chlamydia-induced intestinal infections.

Peer Review reports

Introduction

Zoonoses have attracted much attention globally due to their infectious nature. About 60% of known infectious diseases and 75% of emerging infectious diseases may be directly derived from zoonotic diseases [1, 2], indicating that zoonoses are a threat to global public health. A graver concern pertains to the annual global incidence of zoonotic infections, afflicting an estimated 2.5 billion individuals and resulting in an unfortunate mortality rate of nearly 2.7 million [3]. Emphasizing the imperative, the maintenance of optimal health status among intermediate host animals emerges as the quintessential determinant in preempting the cross-species transmission of zoonoses [4].

Chlamydia is an ancient zoonotic disease with more than 15 different species [5]. Chlamydia is obligate intracellular parasitic, Gram-negative bacteria with a unique biphasic developmental cycle [6, 7]. Although Chlamydia infects different hosts, the disease pathology is similar [8]. Persistent Chlamydia infection can lead to serious sequelae, such as miscarriage, pneumonia, and enteritis since the infection is constantly progressing and it is not easily detectable [9,10,11]. Several studies have shown that Chlamydia migrates to the intestinal tract after infecting the host, develops, and reproduces in the intestinal tract [12, 13]. Chlamydia engraftment may alter gut microbial composition and function, affecting host health by inducing gastrointestinal and metabolic diseases [14, 15].

Horses serve as working animals, exhibit animals, or companions during herding activities, and thus are often in close contact with many individuals. Therefore, humans face a higher risk of contracting diseases from horses than other large animals [16]. Although many studies have shown that zoonotic infectious diseases may disturb the gut microbiota of horses [17,18,19], no study has evaluated gut microbiota changes in horses with Chlamydia. Therefore, this study aimed to characterize gut microbiota changes and serum parameters in horses with Chlamydia and healthy horses. The results of this study could provide a good foundation for comprehending the pathogenesis of Chlamydia-induced intestinal infections in horses, thus safeguarding public health.

Results

Serum biochemical indicators of horse of IG and HG

ALB, TP, AST, TG, MDA, SOD, and CAT levels were not significantly different between the IG and HG groups (P > 0.05; Table 1). However, GLB, ALT, TC, and CK levels were significantly increased in IG than in HG (Table 1).

Table 1 Physiological indicators in IG (n = 10) and HG (n = 6)
Full size table

Bacterial community diversity, richness, and OTUs

A total of 1970 OUT were shared between HG and IG (Fig. 1A). The OUT in the HG and IG were 1987 and 2044, respectively. The samples of HG and IG were distributed discretely and overlapped with each other (P < 0.001, R2 = 0.687), indicating that the samples were reproducible, and HG and IG had different intestinal microorganisms (See Fig. 1B).

The α diversity index analysis showed that the Shannon index and Shannon even index were significantly higher in the IG group than in the HG group (P < 0.001). In contrast, the Simpson index was significantly lower in the IG group than in the HG group (P < 0.001). Notably, the Chao, Ace, and Coverage indexes (P > 0.05) were not significantly different between the HG and IG groups (Fig. 1C).

Fig. 1
figure 1

Gut microbial diversity in IG. A Venn diagram showing the different and similar OTUs in the IG (n = 10) and HG (n = 6) groups. B PcoA showing the OTUs distribution in HG and IG. C Shannon index analysis (the gut microbial diversity was significantly increased in IG than in HG) and Simpson index analysis (the gut microbial diversity was significantly decreased in IG than in HG) (* P < 0.05, ** P < 0.01, *** P < 0.001)

Full size image

Composition of the gut microbiota

The taxa composition and variation of the gut microbiota in HG and IG were analyzed based on the derivation cohort (average relative abundance ≥ 1%). The average composition and relative abundance in gut microbiota at the phylum and genus levels are shown in Fig. 2. Firmicutes, Bacteroidetes, and Proteobacteria were the most predominant phylum in the gut. Compared with HG, the abundance of Firmicutes (44.59% vs. 34.01%, P < 0.01), Bacteroidetes (35.10% vs. 25.22%, P < 0.001), and Spirochaetes (3.71% vs. 2.03%, P < 0.01) was significantly increased in IG, while Proteobacteria abundance (7.66% vs. 29.23%, P < 0.001) decreased (Fig. 2A and B). Furthermore, the abundance of 5 bacteria, such as Clostridia, Bacteroidia, Spirochaetia, and Negativicutes increased in IG, while the abundance of 3 bacteria, including Gammaproteobacteria and Verrucomicrobiae decreased (P < 0.05) (Table S1). The gut microbiota community was also analyzed at the order, family, and genus levels (Fig. 2C, Table S2, and S3). The abundance of 11 bacteria, including Treponema (3.47%), Phascolarctobacterium (2.75%), Prevotella (1.47%), Streptococcus (1.42%), Paraprevotella (0.66%), Pseudobutyrivibrio (0.34%), Bacteroidetes (17.06%), Ruminococcaceae (10.87%), Bacteroidales (9.96%), Clostridiales (4.41%), Porphyromonadaceae (4.33%) increased in IG at the genus level, while the abundance of two bacteria, including Psychrobacter (1.44%) and Akkermansia (0.11%) decreased (P < 0.05) (Fig. 2C and D).

LEFSe (Linear Discriminant Analysis Effect Size) analysis was conducted to further identify changes in bacterial taxa composition (Fig. 3). LEFSe showed that 11 clades were more abundant in the HG, while 35 clades were more abundant in the IG. The abundance differences are shown in Fig. S2. Notably, the abundance of Firmicutes and Bacteroidetes was significantly different in IG.

Network analysis demonstrated that Chlamydia infection in horses alters the gut microbial composition and bacterial interactions (Fig. 4). Further results showed that Bacteroides were advantageous and core to IG, while Firmicutes were advantageous and core to HG. In addition, the network structure of the HG group was more complex, characterized by more nodes and links, compared with the IG group, revealing that Chlamydia infection may destabilize gut microbial interactions.

Fig. 2
figure 2

Bacterial compositions in the gut (A, phylum; C, genus) in HG and IG (HG, healthy groups; IG, Infected groups). The relative abundance of the genus was > 1%, * P < 0.05, ** P < 0.01, *** P < 0.001

Full size image
Fig. 3
figure 3

LEFSe cladogram comparing microbial communities between HG and IG horses. The color of the group where taxa are most abundant indicates differences; Red: taxa abundant in HG, Green: taxa abundant in IG.

Full size image
Fig. 4
figure 4

Interaction network of gut microbiota. Correlation network of (A) IG and (B) HG: 16 S rRNA genes in the gut microbiota of the horse, displaying statistically significant interactions with absolute correlation coefficients > 0.6. Node sizes are scaled according to the overall abundance of each taxon in the microbiota

Full size image

Prediction of gut microbial gene function

Gene function prediction of microbial communities was conducted using PICRUSt software based on the gut microbe 16 S rRNA sequencing data in IG and HG. The differential KEGG pathway analysis showed that 32 pathways were significantly different between the IG and HG groups (P < 0.05) (Fig. 5). Specifically, the relative abundances of carbohydrate metabolism, nucleotide metabolism, enzyme families, and biosynthesis of other secondary metabolites significantly increased in IG (P < 0.05). Furthermore, the amino acid metabolism pathway (10.78%, P < 0.01), lipid metabolism (3.60%, P < 0.01), and metabolism of other amino acids (1.67%, P < 0.01) were significantly higher in HG than in IG.

Relationship of serum biochemical indicators with gut bacterial community

A correlation heatmap (correlation threshold > 0.5) of the top 20 species (with high abundances) and serum biochemical indicators (ALB, TP, AST, ALT, TG, CK, MDA, SOD, and CAT) is shown in Fig. 5A. Serum parameters were significantly correlated with the genus (6 positive and 12 negative correlations) (P < 0.05). Specifically, Treponema was significantly negatively correlated with ALT (P < 0.001) and positively correlated with TP (P < 0.05). In addition, ALT was significantly negatively correlated with Prevotella and Paraprevotella, while Saccharofermentans was significantly negatively correlated with AST, TP, and SOD (Fig. 5A, P < 0.05). The correlations between α diversity and serum biochemical indicators were also assessed via Pearson’s correlation analysis and mantel test (Fig. 5B). Results showed that ALT was significantly positively and negatively correlated with Simpson and Shannon indices, respectively (Fig. 5B).

Fig. 5
figure 5

(A) Spearman correlation and clustering analysis between serum biochemical indicators and main bacterial at the genus level (* P < 0.05, ** P < 0.01, *** P < 0.001). ALB: albumin, TP: total protein, AST: aspartate transaminase, ALT: alanine transaminase, TG: triglyceride, CK: creatine Kinase, MDA: malondialdehyde, SOD: superoxide dismutase, CAT: catalase. (B) Pairwise comparisons of serum indicators: The color gradient represents the Pearson correlation coefficient, and the edge width corresponds to the correlation of Mantel’s statistic. Blue represents a significant correlation, while the solid line represents a positive correlation

Full size image
Fig. 6
figure 6

Functional predictions for gut microbiota with significantly different KEGG pathways (P < 0.05) for the IG and HG (KEGG pathways at Level 2 and Level 3)

Full size image

Discussion

This study elucidates changes in the gut microbiota of horses caused by Chlamydia infection. Serum biochemical indicators in the IG and HG group were analyzed and compared. The IG group had higher levels of GLB and ALT (Table 1), similar to a previous human study case [20, 21]. Chlamydia is a zoonotic pathogen that invades host cells, which may trigger stress response and increase ALT levels. The Chlamydia is characterized by the latent infection of the body and the continuous secretion of cytokines, such as Tumor necrosis factor, interleukin (IL)-1β, and IL-6. Moreover, Chlamydia may lead to the continuous damage of multiple organs, such as the liver, kidney, and muscles [22, 23], and increase the permeability of tissue cells, thus increasing ALT levels. Notably, the CK levels were higher in the IG than in HG (Table 1). Chlamydia has a unique biphasic developmental cycle [24], with alternating elementary bodies and reticulate bodies. This allows immune escape, leading to persistent infection [25]. CK is widely found in tissues, such as skeletal muscle, cardiac muscle, and brain [26]. Chlamydia can hide in monocytes and penetrate the blood-brain barrier after continuous infection, thus spreading to brain tissue [27] and increasing CK levels.

Gut microbes are crucial in the digestion and metabolism of nutrients and the maintenance of host health [28, 29]. Chlamydia is a special intracellular pathogen that settles in the gastrointestinal tract, reproductive tract, and other parts after infection, thus changing the ecological niche of the original microbiota [6, 12]. Most studies have focused on the changes in vaginal microbes caused by Chlamydia infection, ignoring Chlamydia effect on gut microbes [30,31,32]. Herein, Firmicutes, Bacteroidetes, and Proteobacteria were the most dominant phyla in the horse gut, accounting for about 82.83% and 83.75% of the gut microbiota in HG and IG (Fig. 2A), respectively. [33] also reported similar results in purebred horses. Furthermore, gut microbiota diversity increased in the IG group while bacterial communities were changed (Fig. 1C). Although high microbial diversity may improve the overall metabolic efficiency of the organism, it may also destabilize the system and reduce ecological stability [34]. For example, oral dysbiosis in patients with lupus erythematosus is associated with a more diverse oral microbiota [35]. In addition, increased microbial diversity may be associated with multiple deleterious effects. Similarly, increased microbial diversity is associated with impaired fertility in women in the US [36].

Horses are closely related to humans and there are over 10.5 million horses worldwide (Food and Agriculture Organization of the United Nations 2017) (www.fao.org/faostat/en/#data/QL accessed on June 8, 2023), increasing the risk of cross-species transmission of Chlamydia between horses and humans [37]. In this study, Chlamydia infection altered the composition of the gut microbiota in horses, indicated by an increased abundance of enteric Streptococcus, Treponema, Prevotella, and Paraprevotella (Fig. 2D). Streptococcus is the main lactic acid producer. An increased abundance of Streptococcus may cause hindgut acidosis in horses, thus exacerbating enteritis [29, 38]. Herein, Prevotella and Paraprevotella abundances were increased in IG. Prevotella and Paraprevotella are common bacterial groups in the gut, mainly involved in cellulose degradation and carbohydrate metabolism, producing short-chain fatty acids (propionic acid, butyric acid, acetic acid, etc.). Furthermore, complex interactions occur among gut microbes, such as competition for resources [39] and cross-feeding [40, 41]. Unlike other intestinal opportunistic pathogens, the survival and reproduction of Chlamydia in the intestinal environment may require a competitive advantage to accelerate the breakdown of fibers and proteins, thereby increasing the abundance of Prevotella and Paraprevotella [42].

In the present study, Moraxellaceae and Psychrobacter dominated the gut microbiota of healthy horses at the order and genus levels (Table S2 and Fig. 2D). Studies have shown that Moraxellale and Psychrobacteriaceae are common on the mucous membranes of animals and humans [43, 44]. However, their role in resisting Chlamydial infection is unknown. A study found that Moraxella is the dominant nasal microbe in healthy children compared with COVID-19 patients. Reducing Moraxellaceae abundance may lead to lipid metabolism and amino acid metabolism disorders [43, 45]. These findings indicate that Moraxellaceae may have a special defense mechanism against intracellular infection. Nonetheless, the pathogenic mechanisms of COVID-19 and Chlamydia are different. Therefore, further studies should assess Moraxella in cell models infected with Chlamydia. In this study, the abundance of Akkermanisa was significantly reduced in the IG group. Akkermanisa is a promising next-generation probiotic [46], which can effectively improve intestinal inflammation, reduce the secretion of inflammatory cytokines, and protect intestinal health [47]. Therefore, Akkermanisa may be used as a new biological agent for the treatment of enteritis caused by Chlamydia infection.

Microorganisms play a key role in immunity, nutrient absorption, and enzyme metabolism [48]. Results showed that carbohydrate metabolism in the gut microbiota was enhanced in the IG group. Carbohydrate provides energy that is easily metabolized and utilized by the body [49]. Chlamydia requires a lot of energy to support its colonization and development after infection and thus may stimulate the utilization of carbohydrates in the body [50, 51]. Herein, lipid metabolism and amino acid metabolism were reduced in IG (Fig. 6). Although lipid metabolism can also be used as an energy source for the body, Chlamydia infection causes cellular immune responses, then produces inflammatory responses and releases cytokines [52, 53], thereby inhibiting lipid metabolism and amino acid metabolism. Furthermore, the inflammatory response can inhibit the synthesis and oxidation of fatty acids while increasing the uptake and utilization of glucose [54], thus enhancing carbohydrate metabolism [55]. However, these results were only based on the predicted metagenomics and may not represent the actual function of gut bacteria. Therefore, future studies should explore the role of these genes in the gut of horses with Chlamydia based on metabolomics.

Although the changes in gut microbes in horses infected with Chlamydia were comprehensively revealed, Chlamydial infection is usually accompanied by an invisible infection. Therefore, the influence of several stages of Chlamydial occurrence, development, and identification on the intestinal tract should be comprehensively analyzed. In addition, the number of horses should be increased in future studies to avoid the influence of environmental and dietary factors. Future studies should also incorporate continuous monitoring of large sample sizes, combining metabolomics and microbiome multiple combinations to reveal the intestinal pathogenesis caused by Chlamydia infection.

Conclusion

In summary, the changes in serum biochemical parameters and gut microbiota in feedlot horses with Chlamydia infection were evaluated. Chlamydia is an intracellular pathogen that settles in the intestinal tract after infection, increasing the diversity of intestinal microorganisms. Herein, the gut microbiota was correlated with serum biochemical markers of Chlamydial infection. Moreover, the gut microbiota changed with increasing disease activity. These results suggest that gut microbiota dysbiosis may promote the development of Chlamydial infection. Interestingly, Akkermanisa was more abundant in the gut of HG than in the IG group, revealing that this family may protect against Chlamydial infection.

Materials and methods

Animal care

The study was conducted following the guidelines of the Administration for Experimental Animal Affairs (Ministry of Science and Technology, China; revised in June 2024). Moreover, the samples collection and the study were approved by the Animal Use and Care Ethics Committee of Lanzhou University (Gansu, China, No. 2010-1 and 2010-2).

Experimental site

The study was conducted in March 2023 at a horse farm in Shandan County (Zhangye City, Gansu Province). The area has an altitude of ≈ 2500 m, an annual average temperature of 0 °C, and a precipitation of 360 mm. The grassland type in the area is known as an alpine meadow based on the comprehensive, sequential classification method. The vegetation types in the area mainly include Gramineae, Cyperaceae, Fabaceae, Compositae, and Rosaceae.

Animal husbandry and samples

The horses were mixed bred with horses grazing in summer and housed while feeding in winter. The horses had the same diet and were free to drink water and lick brick salt. Moreover, the horses had free access to light and the external environment (temperature and activity space).

However, the horses were reported to experience abortion. A surveillance study was conducted to examine the epidemiology of abortive pathogens. Briefly, fecal samples were collected from the interior of the anus in the early morning (at 09:00 h) without stimulation for three consecutive days and immediately placed in 50 mL sterile propylene tubes with a filter cap. The samples were immediately stored at -20 °C, and transported on ice to the State Key Laboratory of Livestock Diseases, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences.

Blood samples were also collected through the jugular vein before morning feeding and centrifuged at 3000 rpm at 4 °C for 15 min to obtain serum. The serum was separated and placed in a 2 mL centrifuge tube at -20 °C for subsequent analysis.

Chlamydia testing and serum biochemical assays

A fluorescent quantitative PCR (qPCR) was used to detect the pathogens causing miscarriage. The primers and probes used in this analysis are listed in Table S1. The reaction system (20 µL) contained 6 µL of dd H2O, 0.8 µL of upstream primer and downstream primer each, 10 µL of 2×Quantinova Green PCR Master Mix, and 2 µL of the sample. Positive and negative controls were also set up. The program detection was conducted as follows: 45 cycles of pre-denaturation at 95 °C for 3 min, denaturation at 95 °C for 30 s, and annealing at 55 °C for 30 s. The CT value < 35 was considered positive during the preparation of positive and negative controls (Fig. S1).

Epidemiological and clinical investigations detected Chlamydia infection (Fig. S1), with an incidence rate of 57.87% (unpublished data). Sixteen healthy Shandan mares (48 months old) were randomly selected from a herd housed in the same barn for further study to avoid confounding factors, such as environmental factors and other diseases. The horses were divided into two groups: 6 into the uninfected (HG) horses and 10 into the Chlamydia-infected horses (IG).

Albumin (ALB), globulin (GLB), total protein (TP), aspartate transaminase (AST), alanine transaminase (ALT), total cholesterol (TC), triglyceride (TG), creatine kinase (CK), malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT) using the respective kit (Jiangsu Jingmei Biological Technology Co., Ltd, China).

Deoxyribonucleic acid (DNA) extraction, amplification, and sequencing

Library construction and sequencing of specific amplification products were completed by Sangon Bioengineering Co., Ltd. Target sequence amplification was conducted via a two-step PCR method (compatible with Illumina sequencing library preparation). The volume of the first round of the PCR system (25 µL) contained 2 µL DNA template, 1 µL upstream primer, 1 µL downstream primer, and 15 µL 2×PCR Ready Mix. The PCR execution program was as follows: pre-denaturation at 98 °C for 3 min, followed by 8 cycles of denaturation at 98 °C for 30 s, annealing at 60 °C for 30 s, extension at 72 °C for 30 s, and extension at 72 °C for 5 min. The PCR product was recovered using AMPure XP magnetic beads after the size of the product was confirmed. The second round of PCR reaction then obtained a sequenced tagged molecular library. Briefly, the reaction system (30 µL) contained 2 µL DNA template, 1 µL P7 primer with molecular tag, 1 µL P5 primer with molecular tag, and 15 µL 2×PCR Ready Mix. The PCR reaction program was conducted as follows: pre-denaturation at 98 °C for 5 min, followed by five cycles of denaturation at 94 °C for 30 s, annealing at 55 °C for 30 s, extension at 72 °C for 30 s, and extension at 72 °C for 5 min. Notably, the PCR products were recovered using AMPure XP magnetic beads, while NovaSeq6000/ MiSeq sequencer (Illumina, San Diego, CA) was used for paired-end sequencing (150 bp/300 bp).

The high-throughput sequencing data first underwent quality control. Second, the linker sequence was excised using Cutadapt (v 1.2.1) software, while the positive and negative sequences of the same sequence were spliced using Pear (v 0.9.6) software. The sliding window method was used to remove low-quality base sequences via Pinseq-lite (v 0.19.5) software (the minimum Q value; 20, window value; 5, and length threshold; 50). Chimeric sequences were further removed using the search (v 11.06.66) software in de novo mode. Finally, the target sequence was matched according to the upstream and downstream primers through the Python program. Multiple sequence alignment was performed.

Statistical analysis

The Serum biochemical indicators (ALB, GLB, TP, AST, ALT, TC, TG, CK, MDA, SOD, and CAT) and alpha diversity indexes (Ace Index, Chao1 Index, Shannon Index, Simpson Index, Shannon even Index, Sobs and Coverage Index) were analyzed using a completely randomized design based on one-way analysis of variance (ANOVA) (version 24.0, software SPSS Inc., Chicago, IL, USA). A significant tendency was detected at 0.01 ≤ P ≤ 0.05. Key taxa of the microbial community were identified using a microbial network based on a composite score of high mean, high proximity centrality, and low betweenness centrality. The correlation between the bacterial genera and Serum biochemical indicators was evaluated using a Spearman correlation test.

Data Availability

The datasets presented in this study can be found in online repositories. The name of the repository and accession number can be found below: NCBI; PRJNA996933.

References

  1. Petersen E, Petrosillo N, Koopmans M, Beeching N, Di Caro A, Gkrania-Klotsas E, et al. Emerging infections—an increasingly important topic: review by the emerging infections task force. Clin Microbiol Infect. 2018;24(4):369–75.

    PubMed  CAS  Google Scholar 

  2. Acharya KP, Acharya N, Phuyal S, Upadhyaya M, Lasee S. One-health approach: a best possible way to control rabies. One Health. 2020;10:100161.

    PubMed  PubMed Central  Google Scholar 

  3. Gebreyes WA, Dupouy-Camet J, Newport MJ, Oliveira CJ, Schlesinger LS, Saif YM, et al. The global one health paradigm: challenges and opportunities for tackling infectious diseases at the human, animal, and environment interface in low-resource settings. Plos Negl Trop Dis. 2014;8(11):e3257.

    PubMed  PubMed Central  Google Scholar 

  4. Chakraborty C, Bhattacharya M, Nandi SS, et al. Appearance and re-appearance of zoonotic disease during the pandemic period: long-term monitoring and analysis of zoonosis is crucial to confirm the animal origin of SARS-CoV-2 and monkeypox virus. Vet Quart. 2022;42(1):119–24.

    CAS  Google Scholar 

  5. Vorimore F, Hölzer M, Liebler-Tenorio EM et al. Evidence for the existence of a new genus Chlamydiifrater gen. nov. inside the family Chlamydiaceae with two new species isolated from flamingo (Phoenicopterus roseus): Chlamydiifrater phoenicopteri sp. nov. and chlamydiifrater volucris sp. nov. Syst Appl Microbiol;2021,44(4):126200.

  6. Cheong HC, Lee CYQ, Cheok YY, Tan GMY, Looi CY, Wong WF. Chlamydiaceae: Diseases in primary hosts and zoonosis. Microorganisms. 2019;7(5):146.

    PubMed  PubMed Central  CAS  Google Scholar 

  7. Elwell C, Mirrashidi K, Engel J. Chlamydia cell biology and pathogenesis. Nat Rev Microbiol. 2016;14(6):385–400.

    PubMed  PubMed Central  CAS  Google Scholar 

  8. Ravichandran K, Anbazhagan S, Karthik K, Angappan M, Dhayananth B. A comprehensive review on avian chlamydiosis: a neglected zoonotic disease. Trop Anim Health Prod. 2021;53:1–17.

    Google Scholar 

  9. Polkinghorne A, Greub G. A new equine and zoonotic threat emerges from an old avian pathogen, Chlamydia psittaci. Clin Microbiol Infect. 2017;23(10):693–4.

    PubMed  CAS  Google Scholar 

  10. Turin L, Surini S, Wheelhouse N, Rocchi MS. Recent advances and public health implications for environmental exposure to Chlamydia abortus: from enzootic to zoonotic disease. Vet Res. 2022;53(1):1–17.

    Google Scholar 

  11. Gautam J, Krawiec C. Chlamydia pneumonia. 2020; PMID 32809709.

  12. Zhong G. Chlamydia overcomes multiple gastrointestinal barriers to achieve long-lasting colonization. Trends Microbiol. 2021;29(11):1004–12.

    PubMed  PubMed Central  CAS  Google Scholar 

  13. He C, Xu Y, Huo Z, Wang J, Jia T, Li XD, et al. Regulation of Chlamydia spreading from the small intestine to the large intestine via an immunological barrier. Immunol Cell Biol. 2021;99(6):611–21.

    PubMed  CAS  Google Scholar 

  14. Gacesa R, Kurilshikov A, Vich Vila A, Sinha T, Klaassen M, Bolte L, et al. Environmental factors shaping the gut microbiome in a dutch population. Nature. 2022;604(7907):732–9.

    PubMed  CAS  Google Scholar 

  15. de Vos WM, Tilg H, Van Hul M, Cani PD. Gut microbiome and health: mechanistic insights. Gut. 2022;71(5):1020–32.

    PubMed  Google Scholar 

  16. Dwyer RM. Equine zoonoses: consequences of horse-human interactions. Zoonoses-Infections Affecting Humans and Animals: Focus on Public Health Aspects. 2014:643 – 57.

  17. Clark A, Sallé G, Ballan V, Reigner F, Meynadier A, Cortet J, et al. Strongyle infection and gut microbiota: profiling of resistant and susceptible horses over a grazing season. Front Physiol. 2018;9:272.

    PubMed  PubMed Central  Google Scholar 

  18. Akter R, El-Hage CM, Sansom FM, Carrick J, Devlin JM, Legione AR. Metagenomic investigation of potential abortigenic pathogens in foetal tissues from australian horses. BMC Genomics. 2021;22(1):1–14.

    Google Scholar 

  19. Costa MC, Arroyo LG, Allen-Vercoe E, Stämpfli HR, Kim PT, Sturgeon A, et al. Comparison of the fecal microbiota of healthy horses and horses with colitis by high throughput sequencing of the V3-V5 region of the 16S rRNA gene. PLoS ONE. 2012;7:e41484.

    PubMed  PubMed Central  CAS  Google Scholar 

  20. Kong C-Y, Zhu J, Lu J-J, Xu Z-H. Clinical characteristics of Chlamydia psittaci pneumonia. Chin Med J-Peking. 2021;134(03):353–5.

    CAS  Google Scholar 

  21. Zhang A, Xia X, Yuan X, Liu Y, Niu H, Zhang Y et al. Severe Chlamydia psittaci pneumonia complicated by rhabdomyolysis: a case series. Infect Drug Resist. 2022:873–81.

  22. Datta B, Njau F, Thalmann J, Haller H, Wagner AD. Differential infection outcome of Chlamydia trachomatis in human blood monocytes and monocyte-derived dendritic cells. BMC Microbiol. 2014;14(1):1–14.

    Google Scholar 

  23. Cheong HC, Lee CYQ, Cheok YY, Shankar EM, Sabet NS, Tan GMY, et al. CPAF, HSP60 and MOMP antigens elicit pro-inflammatory cytokines production in the peripheral blood mononuclear cells from genital Chlamydia trachomatis-infected patients. Immunobiology. 2019;224(1):34–41.

    PubMed  CAS  Google Scholar 

  24. Brunham RC, Rey-Ladino J. Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol. 2005;5(2):149–61.

    PubMed  CAS  Google Scholar 

  25. Brinkworth AJ, Wildung MR, Carabeo RA. Genomewide transcriptional responses of iron-starved Chlamydia trachomatis reveal prioritization of metabolic precursor synthesis over protein translation. Msystems. 2018;3(1):e00184–17.

    PubMed  PubMed Central  CAS  Google Scholar 

  26. Baird MF, Graham SM, Baker JS, Bickerstaff GF. Creatine-kinase-and exercise-related muscle damage implications for muscle performance and recovery. J Nutr Metab. 2012;2012.

  27. Cheok YY, Lee CYQ, Cheong HC, Looi CY, Wong WF. Chronic inflammatory diseases at secondary sites ensuing urogenital or pulmonary Chlamydia infections. Microorganisms. 2020;8(1):127.

    PubMed  PubMed Central  CAS  Google Scholar 

  28. Fassarella M, Blaak EE, Penders J, Nauta A, Smidt H, Zoetendal EG. Gut microbiome stability and resilience: elucidating the response to perturbations in order to modulate gut health. Gut. 2021;70(3):595–605.

    PubMed  CAS  Google Scholar 

  29. Garber A, Hastie P, Murray J-A. Factors influencing equine gut microbiota: current knowledge. J Equine Vet Sci. 2020;88:102943.

    PubMed  Google Scholar 

  30. Edwards VL, Smith SB, McComb EJ, Tamarelle J, Ma B, Humphrys MS, et al. The cervicovaginal microbiota-host interaction modulates Chlamydia trachomatis infection. MBio. 2019;10(4):e01548–19.

    PubMed  PubMed Central  CAS  Google Scholar 

  31. Filardo S, Di Pietro M, Tranquilli G, Latino MA, Recine N, Porpora MG, et al. Selected immunological mediators and cervical microbial signatures in women with Chlamydia trachomatis infection. MSystems. 2019;4(4):e00094–19.

    PubMed  PubMed Central  Google Scholar 

  32. Xie G, Hu Q, Cao X, Wu W, Dai P, Guo W et al. Clinical identification and microbiota analysis of Chlamydia psittaci-and Chlamydia abortus-pneumonia by metagenomic next-generation sequencing. Front Cell Infect Mi 13:709.

  33. Wen X, Luo S, Lv D, Jia C, Zhou X, Zhai Q, et al. Variations in the fecal microbiota and their functions of Thoroughbred, Mongolian, and hybrid horses. Front Vet Sci. 2022;9:920080.

    PubMed  PubMed Central  Google Scholar 

  34. Brüssow H. Problems with the concept of gut microbiota dysbiosis. Microb Biotechnol. 2020;13(2):423–34.

    PubMed  Google Scholar 

  35. Guo J, Cui G, Huang W, Zheng Z, Li T, Gao G, et al. Alterations in the human oral microbiota in systemic lupus erythematosus. J Transl Med. 2023;21(1):95.

    PubMed  PubMed Central  Google Scholar 

  36. Fettweis JM, Serrano MG, Brooks JP, Edwards DJ, Girerd PH, Parikh HI, et al. The vaginal microbiome and preterm birth. Nat Med. 2019;25(6):1012–21.

    PubMed  PubMed Central  CAS  Google Scholar 

  37. Sack A, Oladunni FS, Gonchigoo B, Chambers TM, Gray GC. Zoonotic diseases from horses: a systematic review. Vector-Borne Zoonot. 2020;20(7):484–95.

    Google Scholar 

  38. Park T, Cheong H, Yoon J, Kim A, Yun Y, Unno T. Comparison of the fecal microbiota of horses with intestinal disease and their healthy counterparts. Vet Sci. 2021;8(6):113.

    PubMed  PubMed Central  Google Scholar 

  39. Mahowald MA, Rey FE, Seedorf H, Turnbaugh PJ, Fulton RS, Wollam A, et al. Characterizing a model human gut microbiota composed of members of its two dominant bacterial phyla. P Natl Acad Sci Usa. 2009;106(14):5859–64.

    CAS  Google Scholar 

  40. Rey FE, Faith JJ, Bain J, Muehlbauer MJ, Stevens RD, Newgard CB, et al. Dissecting the in vivo metabolic potential of two human gut acetogens. J Biol Chem. 2010;285(29):22082–90.

    PubMed  PubMed Central  CAS  Google Scholar 

  41. Fan Q, Wanapat M, Yan T, Hou F. Altitude influences microbial diversity and herbage fermentation in the rumen of yaks. BMC Microbiol. 2020;20(1):1–13.

    Google Scholar 

  42. Fei Y, Wang Y, Pang Y, Wang W, Zhu D, Xie M, et al. Xylooligosaccharide modulates gut microbiota and alleviates colonic inflammation caused by high fat diet induced obesity. Front Physiol. 2020;10:1601.

    PubMed  PubMed Central  Google Scholar 

  43. Yu X, Wang L, Zheng X, Wen Y, Zhang Z, Fan L, et al. Moraxella occupied the largest proportion in the nasal microbiome in healthy children, which potential protect them from COVID-19. Microb Pathog. 2022;170:105685.

    PubMed  PubMed Central  CAS  Google Scholar 

  44. Holman DB, Yang W, Alexander TW. Antibiotic treatment in feedlot cattle: a longitudinal study of the effect of oxytetracycline and tulathromycin on the fecal and nasopharyngeal microbiota. Microbiome. 2019;7(1):1–14.

    Google Scholar 

  45. Qiu H, Gao H, Yu F, Xiao B, Li X, Cai B, et al. Perinatal exposure to low-level PBDE-47 programs gut microbiota, host metabolism and neurobehavior in adult rats: an integrated analysis. Sci Total Environ. 2022;825:154150.

    PubMed  CAS  Google Scholar 

  46. Zhang T, Li Q, Cheng L, Buch H, Zhang F. Akkermansia muciniphila is a promising probiotic. Microb Biotechnol. 2019;12(6):1109–25.

    PubMed  PubMed Central  Google Scholar 

  47. Zhang T, Ji X, Lu G, Zhang F. The potential of Akkermansia muciniphila in inflammatory bowel disease. Appl Microbiol Biot. 2021;105:5785–94.

    CAS  Google Scholar 

  48. Martin R, Nauta A, Ben Amor K, Knippels L, Knol J, Garssen J. Early life: gut microbiota and immune development in infancy. Benef Microbes. 2010;1(4):367–82.

    PubMed  CAS  Google Scholar 

  49. Payling L, Fraser K, Loveday S, Sims I, Roy N, McNabb W. The effects of carbohydrate structure on the composition and functionality of the human gut microbiota. Trends Food Sci Tech. 2020;97:233–48.

    CAS  Google Scholar 

  50. Goyal P, Rajala MS. Reprogramming of glucose metabolism in virus infected cells. Mol Cell Biochem. 2023:1–10.

  51. Zhang P, Pan S, Yuan S, Shang Y, Shu H. Abnormal glucose metabolism in virus associated sepsis. Front Cell Infect Mi. 2023;13:392.

    CAS  Google Scholar 

  52. Darville T, Hiltke TJ. Pathogenesis of genital tract disease due to Chlamydia trachomatis. J Infect Dis. 2010;201(Supplement 2):114–S25.

    Google Scholar 

  53. Redgrove KA, McLaughlin EA. The role of the immune response in Chlamydia trachomatis infection of the male genital tract: a double-edged sword. Front Immunol. 2014;5:534.

    PubMed  PubMed Central  Google Scholar 

  54. Chen Y, Yu CY, Deng WM. The role of pro-inflammatory cytokines in lipid metabolism of metabolic diseases. Int Rev Immunol. 2019.

  55. Lackey DE, Olefsky JM. Regulation of metabolism by the innate immune system. Nat Rev Endocrinol. 2016;12(1):15–28.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

We thank two anonymous reviewers for their constructive comments and suggestions, which have significantly improved the paper.

Funding

This research was supported by the Gansu Provincial Key R&D Program (21YF5FA152), Basic scientific research business expenses project of Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences (1610312021012)  and the National Key R&D Program (2022YFC2304000).

Author information

Author notes

  1. Youshun Jin and Wei Li have contributed equally to this work

Authors and Affiliations

  1. State Key Laboratory for Animal Disease Control and Prevention, Key Laboratory of Veterinary Public Health of Agriculture Ministry Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou, 730046, China

    Youshun Jin, Wei Li, Xuli Ba, Yanyan Wang, Zhaocai Li & Jizhang Zhou

  2. State Key Laboratory for Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou Veterinary Research Institute, Lanzhou University, Chinese Academy of Agricultural Sciences, Lanzhou, 730000, China

    Youshun Jin, Xuli Ba & Jizhang Zhou

  3. Animal Pathology Laboratory, College of Veterinary Medicine, Northwest A&F University, Xianyang, 712100, China

    Yunhui Li & Huaiyu Zhang

Authors
  1. Youshun Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Wei Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xuli Ba
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yunhui Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yanyan Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Huaiyu Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Zhaocai Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jizhang Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

The experiment was conceived and designed by JZZ, YSJ and WL, and performed by YSJ and WL. Data analysis was performed by YSJ and WL. Paper writing were conducted by YSJ and WL. XLB, YHL, YYW, YHZ and ZCL have helped in revision and approved the final manuscript. All authors reviewed the manuscript.

Corresponding author

Correspondence to Jizhang Zhou.

Ethics declarations

Ethics approval and consent to participate

I obtained written informed consent to use the animals in my study from the owner(s) of the animals.

Consent for publication

Not applicable.

Competing interests

The authors have no conflicts of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Jin, Y., Li, W., Ba, X. et al. Gut microbiota changes in horses with Chlamydia. BMC Microbiol 23, 246 (2023). https://doi.org/10.1186/s12866-023-02986-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12866-023-02986-8

Keywords

BMC Microbiology

ISSN: 1471-2180

Contact us